Europe Nutrition and Supplements Market To Reach $52.9 Billion By 2025: Grand View Research, Inc.


The Europe nutrition and supplements market is expected to reach USD 52.9 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 5.9% during the forecast period. It is primarily driven by increasing awareness about healthy lifestyle, weight management, sports nutrition, healthy eating, and wellbeing.

Growing geriatric population and surging healthcare costs in the region are among the key trends estimated to trigger market growth. Increasing health consciousness among consumers and rising willingness to spend on nutrition and dietary supplements are also projected to augur well for the growth of the market. Moreover, upswing in the number of distribution channels for nutraceuticals is poised to improve their accessibility, which will stimulate the growth of the market.

Spiraling demand for nutraceuticals from consumers and growing emphasis on food content are also anticipated to escalate the growth of the market. In terms of age group, the adult segment dominated the market in 2016 owing to presence of a large target population in the region. However, the children segment is likely to witness the fastest growth with a CAGR of 7.5% over the forecast period owing to rising number of product launches for children & infants and expanding base of children suffering from malnutrition. According to European Commission, 51 million children under 5 years of age are affected by malnutrition and it is one of the main causes of 45.0% of deaths in this age group.



Additional supplements are further segmented into dietary supplements & functional foods. Dietary supplements are expected to register a higher CAGR during the forecast period. These include vitamins, minerals, enzymes, amino acids, and others. Enzyme-based dietary supplements are estimated to experience the fastest growth with a CAGR of 10.0% over the forecast period.

Browse full research report on Europe Nutrition and Supplements Market: www.grandviewresearch.com/industry-analysis/europe-nutrition-supplements-market         
Further key findings from the study suggest:        
                             
  • Italy was the leading revenue contributor in the region in 2016 due to soaring adoption of dietary supplements, rising awareness regarding their advantages, and increasing efforts by pharmacists to promote healthy lifestyle
  • The U.K. is the fastest growing market with a CAGR of 7.1% between 2017 and 2025
  • Sports nutrition is the fastest growing segment during the forecast period, which is anticipated to post a CAGR of 7.5%
  • Some of the prominent players operating in this market are Amway; Bayer AG; Sanofi; Abbott; Nestle; Pfizer, Inc.; General Nutrition Centers, Inc.; and LivaNova PLC
Browse more reports of this category by Grand View Research: www.grandviewresearch.com/industry/pharmaceuticals                                                                                                                                                                                                         
Grand View Research has segmented the Europe nutrition and supplements market on the basis of formulation, function, age group, and country:

Europe Nutrition and Supplements Formulation Outlook (Revenue, USD Million, 2014 - 2025)
  • Tablets
  • Capsules
  • Liquid
  • Powder
  • Soft Gels
  • Others
Europe Nutrition and Supplements Function Outlook (Revenue, USD Million, 2014 - 2025)
  • Medical Food
  • Sports Nutrition
  • Additional Supplements
    • Dietary Supplements
      • Vitamins
      • Minerals
      • Enzymes
      • Amino acids
      • Others
    • Functional Foods
Europe Nutrition and Supplements Age Group Outlook (Revenue, USD Million, 2014 - 2025)
  • Infants
  • Children
  • Adults
  • Pregnant
  • Geriatric
Europe Nutrition and Supplements Regional Outlook (Revenue, USD Million, 2014 - 2025)
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
Access Press Release By Grand View Research: www.grandviewresearch.com/press-release/europe-nutrition-supplements-market-analysis                                                                                                                                                                          
About Grand View Research:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more